GOLDMAN SACHS GROUP INC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 193 filers reported holding BEAM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,104,294
-52.1%
461,717
-36.4%
0.00%
-60.0%
Q2 2023$23,181,979
+15.0%
726,025
+10.3%
0.01%
+25.0%
Q1 2023$20,155,860
-49.4%
658,258
-35.4%
0.00%
-55.6%
Q4 2022$39,829,311
-20.5%
1,018,392
-3.2%
0.01%
-25.0%
Q3 2022$50,102,000
+35.7%
1,051,676
+10.2%
0.01%
+50.0%
Q2 2022$36,927,000
-22.3%
953,927
+15.0%
0.01%
-20.0%
Q1 2022$47,516,000
-38.8%
829,247
-14.9%
0.01%
-33.3%
Q4 2021$77,619,000
-14.6%
974,018
-6.7%
0.02%
-21.1%
Q3 2021$90,846,000
+8.9%
1,044,082
+61.1%
0.02%0.0%
Q2 2021$83,410,000
+41.9%
648,044
-11.7%
0.02%
+26.7%
Q1 2021$58,766,000
-14.4%
734,217
-12.7%
0.02%
-16.7%
Q4 2020$68,675,000
+796.1%
841,193
+170.2%
0.02%
+800.0%
Q3 2020$7,664,000
-13.0%
311,289
-1.0%
0.00%
-33.3%
Q2 2020$8,807,000
+34.8%
314,537
-13.3%
0.00%
+50.0%
Q1 2020$6,534,000362,9580.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
HSG Holding Ltd 1,127,934$31,582,0005.60%
Omega Fund Management, LLC 302,821$8,479,0002.32%
Redmile Group, LLC 3,356,958$93,995,0001.74%
BRANDYWINE MANAGERS, LLC 10,875$305,0001.25%
DC Investments Management, LLC 88,100$2,467,0000.91%
Alphabet Inc. 663,691$18,583,0000.86%
Cormorant Asset Management, LP 796,429$22,036,0000.84%
HHLR ADVISORS, LTD. 2,966,403$83,059,0000.76%
Temasek Holdings (Private) Ltd 3,354,641$93,930,0000.56%
Granahan Investment Management 96,598$2,705,0000.10%
View complete list of BEAM THERAPEUTICS INC shareholders